Tag: COVID-19

Dolo 650’s Rise to Fame in India

Amidst the macroeconomic, structural, and microeconomic shifts caused by the COVID-19 pandemic, the Indian pharmaceutical industry responded with agility, exceeding the expectations of governments and markets across geographies. The overall growth of the Indian pharmaceutical industry can be largely attributed to the industry’s leadership in supplying generic formulations to the market, supplying over 40% of

Will New Anti-COVID Pills Live Up to the Hype?

Since the onset of the COVID-19 pandemic in 2020, researchers have been continuously striving towards developing effective therapies to contain the virus and minimize its implications on the affected individuals. While wearing masks, social-distancing, sanitization, and vaccination remained the leading options for preventing the transmission of infections, the upsurge in the latest coronavirus mutation, Omicron

Top Trends to Look Out for in the HealthTech Industry in 2022

The coronavirus pandemic in 2020 has dramatically altered the way healthcare is practiced across the world. Even 2021 presented its own set of challenges for healthcare providers, such as divergent views on vaccines, powerful COVID-19 variants, lack of certain medical equipment. Amidst all the chaos, the healthtech industry managed to overcome all the difficulties by

Can Herd Immunity End the COVID-19 Pandemic?

The COVID-19 pandemic has created an unprecedented situation worldwide, causing millions of deaths and significant damage to the world economy. For more than a year, people have heard and hoped for herd immunity that may be achievable in the long-term with near-universal vaccination. Do the low infection rates around the world suggest that COVID-19 herd

Indian Chemical Industry Counts Losses and Gains in Global Chemical & Petrochemical Industry Amid COVID-19

The coronavirus (COVID-19) outbreak further hit the possibility of revival in the global economy as the death toll rises to more than 3200 in 86 countries with number of positive cases rising to more than 87,000 as of March 2020. Taking into consideration the ongoing economic disruption and prolonged suffering to the human life due